1.	Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H0901329, NCT01189409
2.	Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-038, NCT01200355
3.	Paracetamol for Cancer Pain Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: Par 06-0045, NCT01313247
4.	Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 21 and under Sponsor: Other Protocol IDs: TASMC-11-MB-442-CTIL, NCT01339988
5.	Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes Phase: Phase IV Type: Treatment Status: Active Age: 10 to 90 Sponsor: Other Protocol IDs: MST/MDS-307PLAH-ASH, NCT01674985
6.	Fentanyl for Breakthrough Pain in the Emergency Department Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 to 75 Sponsor: Other, Pharmaceutical / Industry Protocol IDs: 2012-0982, NCT01812759
7.	CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 months to 21 years Sponsor: Other Protocol IDs: #1R01FD003410-01, R01 FD003410-01-A1, NCT00999713
8.	Low-energy Laser Therapy for Prevention of Oral Mucositis in Children Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Active Age: 0 to 18 Sponsor: Other Protocol IDs: CHU-0060, NCT01007617
9.	Nanoemulsion and Lipid Emulsion of Propofol in a Non-invasive Ambulatory Procedures Children Phase: Phase III, Phase II Type: Supportive care Status: Approved-not yet active Age: 6 to 12 Sponsor: Pharmaceutical / Industry Protocol IDs: CRIST011, NCT01326078
10.	Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H-4-2010-046, NCT01404520
11.	Stem Cell Transplant for Hematological Malignancy Phase: Phase III Type: Treatment Status: Active Age: 54 and under Sponsor: Other Protocol IDs: 0107M05202, MT2001-02, NCT00176930
12.	Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases Phase: Phase III Type: Supportive care Status: Active Age: 15 to 79 Sponsor: Other Protocol IDs: C-SHOT 0402, NCT00137787
13.	Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Active Age: 16 to 65 Sponsor: NCI Protocol IDs: CBMTG-0601, NCT00438958
14.	Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies Phase: Phase III Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: SCT 0307, NCT00619879
15.	Trial of a Breathlessness Intervention Service for Intractable Breathlessness Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PB-PG-0107-11134, ISRCTN04119516, NCT00678405
16.	Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: RICMAC, EBMT 42205525, NCT00682396
17.	Improving Clinician Communication Skills (ICCS) Phase: Phase III Type: Educational/Counseling/Training, Health services research Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 31466-G, R01NR009987, NCT00687349
18.	Intrapleural Catheter Daily Versus Three Times a Week Drainage Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2007-0808, NCT00761618
19.	Exercise During Chemotherapy for Patients With Hematological Malignancies Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: EA4/031/09, NCT00884364
20.	Randomized Allogeneic Azacitidine Study Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2008-0503, NCT00887068
21.	Pharmacologic Optimization of Voriconazole Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VORI911, NCT00893555
22.	Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Active Age: 19 and under Sponsor: Other Protocol IDs: ProfGVHD1, NCT00934557
23.	Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CICL670A2302, 2009-012418-38, NCT00940602
24.	Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI) Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Esperanz-001, M010-025, NCT01136005
25.	Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer Phase: Phase III Type: Supportive care Status: Active Age: 18 and 120 Sponsor: Pharmaceutical / Industry Protocol IDs: IN 0901 INT, 2009-018141-20, NCT01130025